The Food and Drug Administration is supposed to be the global gold standard for drug approvals, but the start of 2025 has drawn outsized concern from various corners in the healthcare industry. From staffing issues, including the scandalous resignation and rehiring of a key agency official, to increases in delays and denials of new drug applications, the FDA’s direction […]
Author Archives: Elizabeth Hicks
Elizabeth Hicks is the U.S. Affairs Analyst with the Consumer Choice Center. She wrote this for InsideSources.com.
